Brooke Parin

Associate

硅谷 + 1.650.687.4124

联系：

Share

Brooke Parin advises clients on capital markets transactions, securities law compliance, periodic reporting, and corporate governance matters.

Brooke's practice includes initial public offerings, follow-on offerings, "at-the-market" (ATM) capital raising programs, and other public company financings. Brooke has experience representing clients in the life sciences and health care industries.

经验

  • Nanobiotix completes $100 million follow-on offering of ADSs, Ordinary Shares, and Pre-Funded WarrantsJones Day represented Nanobiotix S.A., a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, in a global follow-on offering of American Depositary Shares, Ordinary Shares, and Pre-Funded Warrants for an aggregate gross proceeds of approximately $100 million.
  • Anteris Technologies establishes $250 million at-the-market equity programJones Day represented Anteris Technologies Global Corp. (NASDAQ: AVR; ASX:AVR) ("Anteris") in connection with the establishment of an at-the-market equity program for the sale of up to $250 million of its shares of Common Stock.
  • SAP acquires ReltioJones Day advised SAP SE on the acquisition of Reltio, Inc., a leading master data management (MDM) software provider, to help customers make their SAP and non-SAP enterprise data AI-ready.
  • Lyft expands in London with Gett UK acquisitionJones Day is advising Lyft, Inc. on its acquisition of the United Kingdom business of Gett, one of London’s leading black cab apps.
  • Wells Fargo-led syndicate provides $250 million acquisition loan secured by seven data centers in seven statesJones Day advised Wells Fargo Bank, National Association, as administrative agent and lender, in connection with a $250 million syndicated acquisition loan secured by seven data center properties across Arizona, California, Indiana, Missouri, North Carolina, Texas, and Virginia.
    •

    发送前请注意

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice